Evaluation of ivermectin and vitamin E based combination with antiseizure rufinamide drug for mitigation of pentylenetetrazole-induced kindling, behavioral challenges and histopathological aberrations.

MLA

Sabir, A., et al. “Evaluation of Ivermectin and Vitamin E Based Combination with Antiseizure Rufinamide Drug for Mitigation of Pentylenetetrazole-Induced Kindling, Behavioral Challenges and Histopathological Aberrations.” Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society, vol. 75, no. 3, June 2024. EBSCOhost, https://doi.org/10.26402/jpp.2024.2.01.

APA

Sabir, A., Tehreem, S., Farooq, M., Ashraf, W., Javaid, S., Ahmad, T., Alsanea, S., Alqahtani, F., & Imran, I. (2024). Evaluation of ivermectin and vitamin E based combination with antiseizure rufinamide drug for mitigation of pentylenetetrazole-induced kindling, behavioral challenges and histopathological aberrations. Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society, 75(3). https://doi.org/10.26402/jpp.2024.2.01

Chicago

Sabir, A, S Tehreem, M Farooq, W Ashraf, S Javaid, T Ahmad, S Alsanea, F Alqahtani, and I Imran. 2024. “Evaluation of Ivermectin and Vitamin E Based Combination with Antiseizure Rufinamide Drug for Mitigation of Pentylenetetrazole-Induced Kindling, Behavioral Challenges and Histopathological Aberrations.” Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society 75 (3). doi:10.26402/jpp.2024.2.01.